Affluent Medical SAS
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardio… Read more
Affluent Medical SAS (AFME) - Total Assets
Latest total assets as of June 2025: €59.84 Million EUR
Based on the latest financial reports, Affluent Medical SAS (AFME) holds total assets worth €59.84 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Affluent Medical SAS - Total Assets Trend (2016–2024)
This chart illustrates how Affluent Medical SAS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Affluent Medical SAS - Asset Composition Analysis
Current Asset Composition (December 2024)
Affluent Medical SAS's total assets of €59.84 Million consist of 20.0% current assets and 80.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €1.23 Million | 2.0% |
| Accounts Receivable | €3.45 Million | 5.7% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €1.25 Million | 2.1% |
| Intangible Assets | €15.14 Million | 24.9% |
| Goodwill | €32.20 Million | 52.9% |
Asset Composition Trend (2016–2024)
This chart illustrates how Affluent Medical SAS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Affluent Medical SAS's current assets represent 20.0% of total assets in 2024, an increase from 6.3% in 2016.
- Cash Position: Cash and equivalents constituted 2.0% of total assets in 2024, down from 2.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 76.0% of total assets, a decrease from 93.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 52.9% of total assets.
Affluent Medical SAS Competitors by Total Assets
Key competitors of Affluent Medical SAS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Affluent Medical SAS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Affluent Medical SAS generates 0.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Affluent Medical SAS is currently not profitable relative to its asset base.
Affluent Medical SAS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 0.45 | 2.69 |
| Quick Ratio | 1.07 | 0.37 | 2.51 |
| Cash Ratio | 0.00 | 0.06 | 0.00 |
| Working Capital | €805.00K | € -7.93 Million | € 4.22 Million |
Affluent Medical SAS - Advanced Valuation Insights
This section examines the relationship between Affluent Medical SAS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.41 |
| Latest Market Cap to Assets Ratio | 0.52 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | €60.86 Million |
| Market Capitalization | $31.64 Million USD |
Valuation Analysis
Below Book Valuation: The market values Affluent Medical SAS's assets below their book value (0.52 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Affluent Medical SAS's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Affluent Medical SAS (2016–2024)
The table below shows the annual total assets of Affluent Medical SAS from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €60.86 Million | +7.48% |
| 2023-12-31 | €56.62 Million | -5.66% |
| 2022-12-31 | €60.02 Million | -14.30% |
| 2021-12-31 | €70.03 Million | +8.04% |
| 2020-12-31 | €64.83 Million | -0.65% |
| 2019-12-31 | €65.25 Million | -3.18% |
| 2017-12-31 | €67.39 Million | +9.19% |
| 2016-12-31 | €61.72 Million | -- |